Barcelona, January 29, 2026 – Catalonia.health CEO Arantxa Sanz participated this week in the third edition of the "Life Sciences Innovation" conference series, co-organised with EY, which on this occasion explored the challenges and opportunities presented by the future regulation of medicines and medical products for the Spanish market.

HIPRA, a biotechnological company and member of Catalonia.health, and Elanco Animal Health have announced a strategic partnership to bring two vaccines against avian metapneumovirus (aMPV) to the United States poultry market.

The Catalan company Rob Surgical, specialising in robotic technology for minimally invasive surgery and a member of Catalonia.health, has inaugurated its first manufacturing plant in El Prat de Llobregat (Barcelona). 

The biotechnology company Inbiomotion,a member of Catalonia.health, has announced that its MAF Test® has been included in the SEOM-GEICAM-SOLTI 2025 Clinical Practice Guidelines for early-stage breast cancer, a key consensus document for clinical decision-making in Spain and an international reference.

CMG MedDev, a consulting company specialising in regulatory affairs, quality management and clinical consulting for medical devices, in vitro diagnostics and solutions based on software and artificial intelligence, and a member of Catalonia.health, has been awarded the 2025 Cum Laude Award for Innovation in Regulatory Consulting for Medical Devices. 

Barcelona, November 2025 – Catalonia.health hosted this November a working visit by the European consortium RISEMED4EU (Regional Innovation for Smart Ecosystems in Health and Medicine in the EU), an initiative bringing together eight regions from eight European countries with the aim of boosting innovation in health and personalised medicine through interregional collaboration and advanced technology

The technology centre Eurecat, a member of Catalonia.health, and the Catalan Institute of Oncology (ICO) have launched a pilot test of a digital platform based on artificial intelligence aimed at promoting healthy habits and emotional management in order to contribute to primary cancer prevention.  

The biopharmaceutical company Oniria Therapeutics, a member of Catalonia.health, is collaborating with the Vall d’Hebron Institute of Oncology (VHIO) and the Institute of Chemical Research of Catalonia (ICIQ) on the development of the innovative drug ONR-001, aimed at the treatment of treatment-resistant colorectal cancer.

The biopharmaceutical company Oryzon Genomics, a member of Catalonia.health, has presented new clinical data on iadademstat in patients with acute myeloid leukaemia (AML) at the 67thAnnual Meeting of the American Society of Hematology (ASH).

Integra Therapeutics, empresa biotecnològica especialitzada en tecnologia de redacció genètica d’última generació, membre de Catalonia.health, ha anunciat el nomenament de Miles Gerson com a president independent del seu Consell d’Administració.